bell
The current prices are delayed by 15 mins, login to check live prices.
Colinz Laboratories Ltd share price logo

Colinz Laboratories Ltd

(531210)

₹61.350.23%

as on 04:01PM, 19 Sep 2024

Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's High

    ₹61.35
    ₹62
  • 52 Week's Low

    52 Week's High

    ₹35.2
    ₹84.4
1 Month Return+ 11.92 %
3 Month Return+ 39.97 %
1 Year Return+ 59.71 %
Previous Close₹61.49
Open₹62.00
Volume534.00
Upper Circuit-
Lower Circuit-
Market Cap₹28.11Cr

Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹28.11 Cr
P/B Ratio1.06
EPS0
Dividend Yield0
SectorPharmaceuticals
ROE5.73

Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹28.11 Cr110.41%0.53NANA
NA₹1,690.10 Cr487.73%0.54₹30 Cr₹227 Cr
BUY₹12,743.87 Cr377.48%0.51₹314 Cr₹2,177 Cr
NA₹190.28 Cr106.75%0.73NANA
BUY₹12,558.73 Cr55.97%0.66-₹95 Cr₹4,051 Cr

Company Information

Colinz Laboratories Ltd is a successful and experienced pharmaceuticals manufacturing and testing company established in 1987. Located near Mumbai, the company is renowned for its extensive in-house testing and quality control laboratory, as well as the experience and expertise of its promotions and personnel. With over 30 years of accumulated knowledge in the industry, Colinz Laboratories Ltd is well positioned to successfully develop and manufacture pharmaceuticals that meet the highest of standards. With full-fledged in-house testing capabilities, the company can ensure that all products are developed and quality-controlled to the highest of standard in order to meet customer expectations.

Share Price: ₹61.35 per share as on 19 Sep, 2024 04:01 PM
Market Capitalisation: ₹28.11Cr as of today
Listing date: 01 Jan, 0001
OrganisationColinz Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Colinz Laboratories Ltd

  • Colinz Labs Reports Decrease in Revenue But Increase in Profit - 02 Aug, 2024

    Despite an 8.04% YoY decrease in revenue, Colinz Laboratories reported a 13.2% YoY increase in profit for Q1. Operating income and EPS also showed positive growth. The company has provided strong returns to investors over various periods.

Insights on Colinz Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Colinz Labs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 78.3% return, outperforming this stock by 18.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.00% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 34.00% of holdings in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, Colinz Labs stock has moved down by -9.2%

Company Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹10.12Cr (-)₹9.93Cr (↓1.88%)₹10.23Cr (↑3.02%)₹11.35Cr (↑10.95%)
Total Liabilities₹2.82Cr (-)₹2.24Cr (↓20.57%)₹2.09Cr (↓6.70%)₹2.40Cr (↑14.83%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹0.58Cr (-)₹2.16Cr (↑272.41%)₹0.47Cr (↓78.24%)₹0.40Cr (↓14.89%)₹1.03Cr (↑157.50%)
0

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
66%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
34%
0.00
Others
0%
0.00

Key Indicators

Details20202021202220232024
Return On Equity %1.92.974.545.815.73

Earnings and Dividends

  • Colinz Laboratories Ltd Earnings Results

    Colinz Laboratories Ltd’s net profit jumped 16.67% since last year same period to ₹0.14Cr in the Q1 2024-2025. On a quarterly growth basis, Colinz Laboratories Ltd has generated 0% jump in its net profits since last 3-months.

    Read More about Earnings Results

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Colinz Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Colinz Laboratories Ltd shares.

Colinz Laboratories Ltd (531210) share price today is ₹61.35

Colinz Laboratories Ltd is not listed on NSE

Colinz Laboratories Ltd is listed on BSE

  • Today’s highest price of Colinz Laboratories Ltd is ₹62.
  • Today’s lowest price of Colinz Laboratories Ltd is ₹61.35.

Today’s traded volume of Colinz Laboratories Ltd(531210) is 534.00.

Today’s market capitalisation of Colinz Laboratories Ltd(531210) is ₹28.11Cr.

Colinz Laboratories Ltd(531210Price
52 Week High
₹84.4
52 Week Low
₹35.2

Colinz Laboratories Ltd(531210) share price is ₹61.35. It is down -27.31% from its 52 Week High price of ₹84.4

Colinz Laboratories Ltd(531210) share price is ₹61.35. It is up 74.29% from its 52 Week Low price of ₹35.2

Colinz Laboratories Ltd(531210Returns
1 Day Returns
-0.14%
1 Month Returns
11.92%
3 Month Returns
39.97%
1 Year Returns
59.71%